PT3402488T - Formas de dosagem orais sólidas de eslicarbazepina - Google Patents
Formas de dosagem orais sólidas de eslicarbazepinaInfo
- Publication number
- PT3402488T PT3402488T PT168750354T PT16875035T PT3402488T PT 3402488 T PT3402488 T PT 3402488T PT 168750354 T PT168750354 T PT 168750354T PT 16875035 T PT16875035 T PT 16875035T PT 3402488 T PT3402488 T PT 3402488T
- Authority
- PT
- Portugal
- Prior art keywords
- eslicarbazepine
- dosage forms
- oral dosage
- solid oral
- solid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN4163DE2015 | 2015-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3402488T true PT3402488T (pt) | 2022-01-25 |
Family
ID=59055907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT168750354T PT3402488T (pt) | 2015-12-18 | 2016-12-16 | Formas de dosagem orais sólidas de eslicarbazepina |
Country Status (6)
Country | Link |
---|---|
US (2) | US10918604B2 (pt) |
EP (2) | EP3957302A1 (pt) |
ES (1) | ES2903037T3 (pt) |
HU (1) | HUE057788T2 (pt) |
PT (1) | PT3402488T (pt) |
WO (1) | WO2017103876A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8372431B2 (en) | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
EP3957302A1 (en) * | 2015-12-18 | 2022-02-23 | Jubilant Generics Limited | Solid oral dosage forms of eslicarbazepine |
WO2019058354A1 (en) * | 2017-09-25 | 2019-03-28 | Jubilant Generics Limited | SUSPENSION OF ESLICARBAZÉPINE |
US11318145B2 (en) | 2018-09-25 | 2022-05-03 | Jubilant Generics Limited | Eslicarbazepine suspension |
WO2020130960A1 (en) * | 2018-12-20 | 2020-06-25 | Mustafa Nevzat Ilac Sanayi A.S. | Oral pharmaceutical compositions of eslicarbazepine |
HUP1900153A1 (hu) | 2019-05-14 | 2020-11-30 | Meditop Gyogyszeripari Kft | Eszlikarbazepin-acetát tartalmú granulátum, ennek elõállítása, ezt tartalmazó egyéb gyógyszerkészítmények, és ezek alkalmazása |
CN112546006B (zh) * | 2020-12-25 | 2022-10-14 | 河北医科大学第二医院 | 一种治疗神经疾病的药物组合物及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT101732B (pt) | 1995-06-30 | 1997-12-31 | Portela & Ca Sa | Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso |
PE20051156A1 (es) | 2004-03-22 | 2006-02-13 | Novartis Ag | Formulaciones de matriz orales que comprenden licarbazepina |
US8372431B2 (en) * | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
TR201008460A1 (tr) * | 2010-10-15 | 2012-05-21 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Eslikarbazepinin saşe formülasyonları. |
RU2625747C2 (ru) * | 2010-12-31 | 2017-07-18 | БИАЛ-ПОРТЕЛА энд КА., С.А. | Грануляты, содержащие эсликарбазепина ацетат |
EP3103444A1 (en) * | 2015-06-09 | 2016-12-14 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical compositions of lacosamide and eslicarbazepine |
EP3957302A1 (en) * | 2015-12-18 | 2022-02-23 | Jubilant Generics Limited | Solid oral dosage forms of eslicarbazepine |
-
2016
- 2016-12-16 EP EP21202491.3A patent/EP3957302A1/en not_active Withdrawn
- 2016-12-16 EP EP16875035.4A patent/EP3402488B1/en active Active
- 2016-12-16 WO PCT/IB2016/057716 patent/WO2017103876A1/en active Application Filing
- 2016-12-16 PT PT168750354T patent/PT3402488T/pt unknown
- 2016-12-16 US US15/742,004 patent/US10918604B2/en active Active
- 2016-12-16 HU HUE16875035A patent/HUE057788T2/hu unknown
- 2016-12-16 ES ES16875035T patent/ES2903037T3/es active Active
-
2021
- 2021-02-05 US US17/169,120 patent/US20210161823A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP3402488A4 (en) | 2019-08-14 |
WO2017103876A1 (en) | 2017-06-22 |
ES2903037T3 (es) | 2022-03-30 |
US20180280307A1 (en) | 2018-10-04 |
US20210161823A1 (en) | 2021-06-03 |
EP3957302A1 (en) | 2022-02-23 |
EP3402488A1 (en) | 2018-11-21 |
US10918604B2 (en) | 2021-02-16 |
EP3402488B1 (en) | 2021-10-27 |
HUE057788T2 (hu) | 2022-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL287437A (en) | Flavociclib solid dosage forms | |
ZA201700301B (en) | Solid oral dosage form of lipophilic compounds | |
IL249946A0 (en) | High Dose Strength Rocaprib Tablets | |
HUE044928T2 (hu) | Ketamin orális dózisformája | |
PT3402488T (pt) | Formas de dosagem orais sólidas de eslicarbazepina | |
EP3346996A4 (en) | ORAL PHARMACEUTICAL PHARMACEUTICAL FORM OF BUDESONID | |
PL3157506T3 (pl) | Kompozycja farmaceutyczna do podawania doustnego o maskowanym smaku | |
ZA201700843B (en) | Oral pharmaceutical composition of isotretinoin | |
GB201607548D0 (en) | Solid dosage form | |
HRP20181406T1 (hr) | Farmaceutski dozni oblici | |
HK1232144A1 (zh) | 經口給藥用醫藥組合物 | |
EP3167870C0 (en) | TAMPER-PROOF ORAL DOSAGE FORM | |
IL252080B (en) | Oral administration of drugs that are unstable or poorly absorbed | |
ZA201509174B (en) | An oral medicinal composition |